The Retrospective Evaluation of Efficacy and Safety Data after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) in Patients Diagnosed with Systemic Lupus Erythematosus: a Single-Center Experience.
European review for medical and pharmacological sciences（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要